A detailed history of Sequoia Financial Advisors, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 25,000 shares of VXRT stock, worth $15,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Previous 97,000 74.23%
Holding current value
$15,750
Previous $64,000 67.19%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$0.58 - $0.99 $41,760 - $71,280
-72,000 Reduced 74.23%
25,000 $21,000
Q2 2024

Jul 15, 2024

BUY
$0.53 - $1.3 $51,410 - $126,100
97,000 New
97,000 $64,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $79.7M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Sequoia Financial Advisors, LLC Portfolio

Follow Sequoia Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.